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SUMMARY  
Infiltrating lipoma is a rare variety of lipoma, characterized by an infiltration of the 
adipose tissue of the muscles. Infiltrating lipomas are usually classified in two groups: 
intermuscular infiltrating lipoma and intramuscular infiltrating lipoma. Most are 
acquired, and they usually appear in middle-aged individuals. Exceptionally, they are 
congenital. In such cases they are not related to other diseases. We report an 8-year-old 
boy with a congenital infiltrating lipoma of the upper limb and von Willebrand disease. 
Both diseases are linked to an alteration in chromosome 12, but this clinical association 
seems to be random rather than causal. 
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Infiltrating lipomas are unusual, benign tumours derived from mature white fat cells; 
they are not capsulated, and have a tendency to infiltrate the muscle tissue and nerve 
fibres. They frequently relapse after surgical excision.1 They are usually acquired, and 
are mainly located in the head and neck,2-5 although other locations6-8 are described. 
Their presence at birth is rare.9-12 Some lipomas are related to specific chromosome 
disorders (chromosome 12q).13-15 Von Willebrand disease (VWD) is a disorder of the 
haemostatic system, characterized by a defect in a protein related to factor VIII.16 It has 
been associated with an alteration in chromosome 12p.17 We present an 8-year-old boy 
with congenital infiltrating lipoma and VWD. However, the association of both unusual 
diseases is probably random rather than causal. 
 
CASE REPORT 
An 8-year-old boy was seen because of a tumour present since birth in the left shoulder 
and forearm. The parents reported that the child showed a slight loss of strength in that 
arm, without change in sensitivity. There was no relevant obstetric history, and the 
mother had not ingested any drug during pregnancy. There was no relevant family 
history. Examination showed a soft, painless mass, without inflammation, located in the 
deltoid area and measuring 10 cm at the base; the mass was in contact with deep 
structures. The tumour could be seen better when the patient contracted the muscle. The 
circumference of the left forearm was almost 3 cm greater than the other forearm, 
without inflammation and without epidermal disorders (Fig. 1). X-ray showed no bony 
abnormalities. Magnetic resonance imaging revealed a fatty tumour on the anterior and 
lateral aspects of the deltoid muscle, extending down to the elbow, but not 
compromising it. In addition, on the anterior aspect of the forearm there was another 
fatty tumour, extending distally to the wrist. This second tumour was dissecting the 
muscular groups, and some of them were atrophic. There were normal vessels inside the 
fat. An electromyograph showed an alteration of potentials in the abductor pollicis 
brevis muscle of the left hand. A biopsy of the fatty tumour showed mature adipose 
tissue infiltrating bundles of skeletal muscle. No atypia or mitoses of fat cells, nor 
multivacuolated lipoblasts or vascular channels, were observed. These findings were 
consistent with an infiltrating lipoma. 
Routine preoperative clotting tests were abnormal, so detailed studies were performed. 
These revealed a bleeding time of 4 min 30 s (normal < 10 s), prothrombin time 89% 
(normal > 75%), kaolin-cephalin time 36 s (normal 25-35), fibrinogen 264 mg dL-1 
(normal 200-500), thrombin time 14´4 s (normal 15-20), factor VIII 47% (normal 
100%), von Willebrand factor antigen 100% (normal 60-140%) and ristocetin cofactor 
activity 50% (normal 100%); multimeric analysis of von Willebrand showed 
proportional reduction of von Willebrand multimeres, and normal multimeric structure, 
consistent with a type I VWD. 
After treatment with desmopressin (DDAVP®, Ferring) we proceeded to operate on the 
patient. Surgical removal of both tumours was performed under general anaesthesia. 
The tumour in the deltoid area was dissecting the fibres of the deltoid muscle, and the 
forearm lipoma was intermuscular. Two years later there was no evidence of tumour 
recurrence and the clotting status was unchanged from the preoperative analysis. The 
patient's father showed similar findings, suggesting that he also presents a VWD type I. 
We could not study the patient's mother. 
 
Cytogenetic analysis 
Tumour genetic analysis was performed by a cytogenetic procedure.18 After surgical 
removal, the sample was disaggregated enzymatically with collagenase, and the 
resulting cells were plated out in plastic flasks and cultured for 10 days. The cultures 
were harvested according to standard procedures. In the subsequent cytogenetic 
analysis, the clonality criteria and the description of karyotypes followed the 
recommendations of the International System for Human Cytogenetic Nomenclature.19 
For comparative genomic hybridization (CGH) analysis, genomic DNA was extracted 
from blocks of paraffin-embedded material by proteinase K digestion. Tumour DNA 
was labelled with fluorescein isothiocyanate-dUTP and normal female reference DNA 
with Texas red-dUTP using a nick translation commercial kit (Vysis). Labelled tumour 
and normal DNAs, together with unlabelled Cot-1 DNA, were mixed and applied on 
male lymphocyte metaphase preparations. The CGH results were analysed with a PSI 
software package and average ratio profiles were determined from eight to 10 
metaphases. We could not detect any genetic aberrations by either G-banding or CGH: 
the tumour cells presented a normal 46,XY karyotype and a normal CGH profile. 
 
DISCUSSION 
Fatty tumours are divided into three types depending on the cells from which they 
derive: lipoblastomas, hibernomas and lipomas,20 the last type being most frequent. 
Most of them are acquired. Infiltrating lipoma is a rare variety, characterized by the 
proliferation of non-capsulated mature fatty tissue which infiltrates the surrounding 
muscle in two ways: intermuscular or intramuscular. Intermuscular infiltrating lipomas 
are more frequent.1-5 Congenital infiltrating lipoma is an unusual type, and only four 
cases have been described, three of them affecting limbs,9-11 and one in the sacral area.12 
Our patient had two infiltrating lipomas in one limb. 
Congenital infiltrating lipoma must be distinguished from other congenital tumours that 
may appear in the first months of life. Lipoblastoma is a congenital tumour. It can 
appear from birth onwards, and is made up of adipoblasts. There are two types, one 
being deeply located and poorly circumscribed, and the other being more superficial and 
well circumscribed.9,21 Other tumours in the differential diagnosis are infiltrating 
angiolipoma, fibrosarcoma, rhabdomyosarcoma and sarcomas of the bones and 
cartilage.12 These are acquired, and the histological characteristics and clinical evolution 
differentiate these entities from congenital infiltrating lipoma. Treatment of infiltrating 
lipoma is by surgical excision, especially if nerve compression and muscular damage 
are present. 
In our patient there was a simultaneous diagnosis of congenital infiltrating lipoma and 
VWD. VWD is an autosomal dominant inherited disease, related to chromosome 12p.16 
In addition, since the initial cytogenetic characterization of lipomas in 1986,22 several 
lipomas have been studied, mostly by conventional cytogenetics. Simple lipomas are 
known to be karyotypically heterogeneous,23 and different genetic subgroups have been 
characterized: those with normal karyotypes, those with 12q13-15 aberrations, 6p 
rearrangements, 13q rearrangements, 8q11-13 aberrations, ring or giant marker 
chromosomes or both, and other chromosomal abnormalities. Normal karyotypes are 
twice as frequent in tumours in patients under 30 years of age than in those from older 
individuals, and are the usual finding in cases of multiple lipoma. In our patient, we did 
not detect genetic aberrations by either G-banding or CGH: the tumour cells had a 
normal karyotype. 
There are three possible reasons for this normal karyotype after cell culture: first, and 
most likely, is that our case belongs to the subgroup of karyotypically normal, multiple 
lipomas in young patients; second, that the cells described as normal are really 
neoplastic cells but with a submicroscopic alteration that we cannot detect at a 
chromosomal level, and third, that normal cells present in the tumour had a growth 
advantage over malignant cell clones, so we only detected the former. To eliminate the 
last possibility we decided to analyse the tumour by CGH (only one cytogenetic study 
by CGH of lipomatous tumours24 has been reported to date). We used archival paraffin 
tissue to select only the tumour cells present in the biopsy. Again, no aberrations were 
detected. As CGH can only detect DNA copy number changes, possible translocations 
or inversion may remain concealed using this technique. 
The significance of cells with a normal karyotype in a neoplastic situation, whether or 
not they represent tumour cells, has been debated. In solid tumours, normal cells are 
usually considered to represent stromal and supporting elements. However, the 
karyotypically normal cells may represent truly neoplastic cells or mask a 
submicroscopic alteration.18 The presence of lipomas with no detectable chromosomal 
abnormalities also highlights the importance of a combined cytogenetic and molecular 
approach in a large series of tumours. 
In conclusion, congenital infiltrating lipoma is an unusual clinical entity. Our patient 
represents the first case where two different congenital infiltrating lipomas are 
described, as he had both intermuscular and intramuscular types of infiltrating lipoma. 
In addition, in this particular case, we think that the association between congenital 
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Figure 1. The tumour in the shoulder can be seen better when the patient contracts the 
muscle. There is a second tumour on the radial aspect of the left forearm, from the 
elbow to the wrist. The base of the thumb is also involved. 
